BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2a study which is being conducted in healthy volunteers in order to evaluate
the comparative reduction of Propionibacterium acnes in-vivo following once daily topical
administration of BPX-01 Minocycline 1% Topical Gel (BPX-01) or BPX-01 Vehicle control.